HOME >> BIOLOGY >> NEWS
Hydroxyurea therapy improves survival in most severely affected sickle cell patients

Sickle cell anemia patients who took the drug hydroxyurea over a 9-year period experienced a 40 percent reduction in deaths, according to the first study to evaluate whether the treatment prolongs life, announced the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.

The study of 299 adult sickle cell patients with moderate to severe forms of the disease, found that improved survival was related to the benefits associated with hydroxyurea treatment an increase in fetal hemoglobin and reduced episodes of severe pain "crises" and chest syndrome, a pneumonia-like illness. The results were published in the April 2 issue of The Journal of the American Medical Association.

Previous research has shown the benefits of hydroxyurea in reducing the symptoms of the most severely affected sickle cell patients those who have 3 or more painful crises each year.

"The current study shows that hydroxyurea can improve the survival of the sickest patients. Now there is new hope for these patients, who typically die 10 to 15 years earlier than patients with milder cases," said NHLBI Director Claude Lenfant, M.D.

Patients in the new study were originally participants in the NHLBI's Multicenter Study of Hydroxyurea (MSH) in Sickle Cell Anemia. That clinical trial was designed to test whether hydroxyurea reduced symptoms of the disease compared to placebo in patients who had 3 or more crises per year. Patients were randomly assigned to hydroxyurea or placebo and the study was "double-blinded" indicating neither patients nor physicians knew who was taking the drug.

Over 2 1/ 2 years, the drug resulted in an almost 50 percent reduction in the number of painful crises and episodes of chest syndrome. Patients on hydroxyurea also required about 50 percent fewer transfusions and hospitalizations. These results, reported in 1995, were reviewed by the Food and Drug Administration (FDA) and hydroxyurea became the first FDA
'"/>

Contact: NHLBI Communications Office
301-496-4236
NIH/National Heart, Lung, and Blood Institute
1-Apr-2003


Page: 1 2 3

Related biology news :

1. Targeted therapy knocks out pediatric brain cancer in mice
2. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
3. Columbia research to examine gene influence on severity of peridontal disease, therapy response
4. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
5. The search for a kinder, gentler chemotherapy
6. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
7. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
8. Gene changes linked to increased eye pressure may have implications for glaucoma therapy
9. Jefferson Lab detector technology aids development of cystic fibrosis therapy
10. Stroking up cellular therapy
11. Smart gene therapy protects against damage from heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/20/2018)... ... November 20, 2018 , ... Like many large breed dogs, Jack, a ... was a year old, his mom, Rebecca, noticed he was slow to get up ... veterinarian and her suspicions were confirmed: Jack had bilateral hip dysplasia, a congenital condition ...
(Date:11/15/2018)... (PRWEB) , ... November 15, 2018 , ... ... integrator of custom industrial automation and IT solutions with 140 employees on both ... Control Systems Integrators Association (CSIA) Certification. CSIA Certified control system integrators ...
(Date:11/15/2018)... ... November 14, 2018 , ... ... MD, founder and medical director of Flatiron Functional Medicine to its Medical Advisory ... Dr. Carnahan will bring to uBiome extensive experience in treating the root causes ...
Breaking Biology News(10 mins):
(Date:11/7/2018)... ... ... Diversified Technologies, Inc. (DTI) has installed a PEF (Pulsed Electric Field) ... Innovation at ASU. Funded by a USDA NIFA SBIR, the purpose of the system ... control applications. , Algae ponds get up to 50% consumed by predators and the ...
(Date:11/5/2018)... ... November 05, 2018 , ... GlycoMark, Inc., the exclusive provider ... its website, http://www.glycomark.com , as part of National Diabetes Month. The ... the website in November from 9 a.m. – 5 p.m. ET weekdays for ...
(Date:10/31/2018)... ... October 30, 2018 , ... Rooam , the premier payment platform ... this winter. After its acquisition of the Tally payment app, the leading payment platform ... tips, Rooam will grow its market share and increase the number of restaurant and ...
(Date:10/31/2018)... ST. LOUIS, Mo. (PRWEB) , ... October 30, 2018 , ... ... Consider Corn Challenge contest. The goal of this global competition is to find new ... competition. , In 2017, America’s corn farmers produced 14.6 billion bushels of corn and ...
Breaking Biology Technology:
Cached News: